ArticleInfection & chemotherapy2022

Nirmatrelvir/Ritonavir Prescription Rate and Outcomes in Coronavirus Disease 2019: A Single Center Study.

Jin Ju Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.